NYSE:ALL • US0200021014
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALLSTATE CORP (ALL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-11 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-05 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2026-02-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-12 | TD Cowen | Downgrade | Buy -> Hold |
| 2026-01-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-12-18 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-12-16 | Mizuho | Initiate | Outperform |
| 2025-12-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-11-26 | Roth Capital | Maintains | Buy -> Buy |
| 2025-11-11 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-11-10 | UBS | Maintains | Buy -> Buy |
| 2025-11-07 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-24 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-08 | UBS | Maintains | Buy -> Buy |
| 2025-09-16 | Wolfe Research | Initiate | Outperform |
| 2025-08-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-08-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 57.094B 11.05% | 64.106B 12.28% | 67.685B 5.58% | 63.32B -6.45% | 67.052B 5.89% | 72.723B 8.46% | 78.439B 7.86% | |
| EBITDA YoY % growth | 904M 244.64% | 6.777B 649.67% | 12.495B 84.37% | 9.473B -24.19% | 8.947B -5.55% | 8.896B -0.57% | N/A | |
| EBIT YoY % growth | 200M 113.59% | 6.222B 3,011.00% | 12.013B 93.07% | 7.914B -34.12% | 7.602B -3.94% | 9.431B 24.06% | N/A | |
| Operating Margin | 0.35% | 9.71% | 17.75% | 12.50% | 11.34% | 12.97% | N/A | |
| EPS YoY % growth | 0.91 182.73% | 18.32 1,913.19% | 34.95 90.78% | 25.49 -27.08% | 25.47 -0.07% | 25.47 -0.01% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.19 103.55% | 4.40 -25.89% | 5.31 -52.45% | 7.82 -45.37% | 7.02 -2.37% | 3.89 -11.62% | 5.40 1.75% | 8.22 5.15% | 7.57 7.91% | 3.83 -1.51% | 6.18 14.39% |
| Revenue Q2Q % growth | 15.299B 7.01% | 16.142B 7.28% | 16.802B 7.50% | 15.693B 7.69% | 16.209B 5.95% | 17.215B 6.65% | 17.941B 6.78% | 16.73B 6.61% | 16.759B 3.39% | 17.842B 3.64% | 18.601B 3.68% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 2.202B 163.71% | 1.312B -31.95% | 1.531B -63.69% | 1.976B -60.74% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
28 analysts have analysed ALL and the average price target is 247.97 USD. This implies a price increase of 20.27% is expected in the next year compared to the current price of 206.17.
ALLSTATE CORP (ALL) will report earnings on 2026-04-29, after the market close.
The consensus EPS estimate for the next earnings of ALLSTATE CORP (ALL) is 7.19 USD and the consensus revenue estimate is 15.30B USD.
The consensus rating for ALLSTATE CORP (ALL) is 77.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.